Projets(s) de recherche, responsable
		Anatomically relevant brachytherapy implants by a 3D printing and radiosenstizing approach, Marc-André Fortin
		A Randomized Trial of Regional Radiotherapy in Luminal A Breast Cancer, Valérie Théberge
		Biochemical and structural studies of poly-TPR containing proteins involved in epigenetic signalling, Amélie Fradet-Turcotte
		Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays., Jacques Simard
		Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy, Francine Durocher
		Decoding the DNA double-strand break repair pathways: from mechanistic insights to human genome instability diseases, Jean-Yves Masson
		Developing synthetic S100A9-based molecules for differentiation therapy of human acute myeloid leukemia, Philippe Tessier
		Effect of environmental contaminants and methylome of breast adipose tissue on aromatase inhibitor efficacy in breast cancer, Caroline Diorio
		Emerging roles of Zinc Finger PAR-Interacting Proteins (ZIPPs) in DNA double-strand break (DSB) repair: implications in PARPi therapy, Guy Poirier
		Implantation d'un registre de données au sein des cliniques de traitement de la douleur du Québec
		L’intégration de la paramédicine communautaire à la clinique (CP@clinic) dans le paysage canadien des soins de santé : Expansion et adaptation de la CP@Clinic afin de l’intégrer dans le système de santé général (Phase 2), Éric Mercier
		Mechanism of Ribosomal RNA Gene Silencing and Its Roles in Pluripotency and Cancer, Thomas Moss
		Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues, Caroline Diorio
		Pre-clinical pharmacokinetic and efficacy assays with an efficient 17beta-hydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy, Sheng-Xiang Lin
		Role and regulation of EPB41L5 in cancer-promoting cellular processes, Patrick Laprise
		Role of MYST-ING acetyltransferase complexes in transcription regulation, cell fate and disease, Jacques Côté
		Role of the RAS Pathway Activation on the Biology and Drug Response of Acute Myeloid Leukemias, Frédéric Barabé
		Targeting sex steroids to improve the response to bladder cancer immunotherapy, Paul Toren
		The BUBR1 pseudokinase in Spindle Checkpoint Activation and Inactivation, Sabine Elowe
		The impact of Monte Carlo dose calculations on prostate and breast low-dose rate brachytherapy dose-outcome relationships and radiobiological modeling, Luc Beaulieu
		The Ribosomal RNA Genes in Growth, Pluripotency, Senescence and Cancer, Thomas Moss
		Understanding mitochondrial metabolism to identify prostate cancer metabolic vulnerabilities, Étienne Audet-Walsh
		Unraveling the molecular mechanisms that promote replication stress and resistance to chemoradiation in oropharyngeal cancer caused by human papillomavirus, Amélie Fradet-Turcotte
		Unravelling the role of primary cilia in prostate cancer initiation and progression, Clémence Belleannée